Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tifenn Lharidon"'
Autor:
Sophie Abadie-Lacourtoisie, Thierry Nguyen-Tan-Hon, Jean-Philippe Spano, Olivier Huillard, Nadine Houede, Hakim Mahammedi, Eric Voog, Yohann Loriot, Tifenn Lharidon, Sheik Emambux, Stéphane Culine, Lionnel Geoffrois, Jean-Christophe Eymard, Mounira El Demery, V. Harter, Vesper Trial Investigators, Philippe Barthélémy, Brigitte Laguerre, Yves Allory, Christine Chevreau, Aline Guillot, Florence Joly, Frédéric Di Fiore, Carolina Saldana, Gwenaelle Gravis, Christian Pfister, Werner Hilgers, Camille Serrate, Guilhem Roubaud, Sabine Vieillot, Aude Fléchon, Frederic Rolland
Publikováno v:
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩
Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩
Background : Cisplatin-based combination chemotherapy before surgery is the standard of care for muscle-invasive bladder cancer. However, the optimal chemotherapy modalities have not been precisely defined to date. Patients and Methods : In the VESPE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d9aa8d1b02aa6db6c212d2664180052
https://doi.org/10.1016/j.clgc.2021.08.005
https://doi.org/10.1016/j.clgc.2021.08.005
Autor:
Tifenn Lharidon, J C Théry, Marie-Ange Mouret Reynier, Philippe Barthélémy, Thomas Filleron, Francesco Del Piano, Marc Debled, Christelle Levy, Monica Arnedos, Alexandra Jacquet, Xavier Tchiknavorian, Florence Dalenc, Alicia Tran-Dien, Anthony Gonçalves, Jean-Marc Ferrero, Fabrice Andre, Mario Campone, Ivan Bièche, Benjamin Verret, Ingrid Garberis, Amélie Lusque, Florence Coussy, Etienne Rouleau, C. Lefeuvre-Plesse, Marie-Paule Sablin, Alice Mege, Marta Jimenez, William Jacot, Benoit You, Thomas Bachelot, Nicolas Isambert, Julien Adam
Publikováno v:
Nature Medicine. 27:250-255
The impact of single-agent antibodies against programmed death-ligand 1 (PD-L1) as maintenance therapy is unknown in patients with metastatic breast cancer. The SAFIR02-BREAST IMMUNO substudy included patients with human epidermal growth factor recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f1d66d2fa2eaedee4082e6c22e8a8b
https://doi.org/10.1038/s41591-020-01189-2
https://doi.org/10.1038/s41591-020-01189-2
Autor:
Eric Legouffe, Thomas Bachelot, Benoit You, Francesco Del Piano, Dominique Beal-Ardisson, Anne-Claire Hardy-Bessard, Tifenn Lharidon, Claire Garnier-Tixidre, Hélène Simon, Rémy Largillier, Mustapha Atlassi, Jean-Philippe Jacquin, Jean-Sebastien Frenel, Antoine Arnaud, Pierre Heudel, Claudiu Cornea, Laetitia Stefani, Sylvie Chabaud, Alain Lortholary, Fabien Brocard
Publikováno v:
Journal of Clinical Oncology. 37:1043-1043
1043 Background: For ER+/HER2- metastatic breast cancer (mBC), efficacy of endocrine therapy + chemotherapy combination remain an open question. We hypothesized that continuing ER targeted therapy after progression in combination with chemotherapy ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c124fad04ef9f25f5f8bb1123cf96ce
https://doi.org/10.1200/jco.2019.37.15_suppl.1043
https://doi.org/10.1200/jco.2019.37.15_suppl.1043
Autor:
Thierry Nguyen Tan Hon, Isabelle Borget, J. F. Berdah, Remy Delva, Florence Joly, Youssef Tazi, Marine Gross-Goupil, Stéphane Culine, Aude Flechon, Tifenn Lharidon, Caroline Cheneau, Emmanuelle Bompas, Karim Fizazi, Gwenaelle Gravis, Philippe Beuzeboc, Geraldine Martineau, Christine Theodore, Giulia Baciarello, Philippe Barthélémy, Mathilde Deblock
Publikováno v:
Journal of Clinical Oncology. 37:5017-5017
5017 Background: Docetaxel and cabazitaxel represent now the standard of care in men with mCRPC with similar efficacy reported in metastatic first-line setting in the FIRSTANA phase 3 trial. We assessed patients’ preference between the two taxanes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30a0d31d9647904a7f3927004b311777
https://doi.org/10.1200/jco.2019.37.15_suppl.5017
https://doi.org/10.1200/jco.2019.37.15_suppl.5017
Autor:
Aline Guillot, Rémy Largillier, Jean-Marc Ferrero, Marc Pujalte Martin, Jean Baptiste Paoli, Julien Viotti, Frank Priou, Benjamin Hoch, Jean-François Tanti, Delphine Borchiellini, Renaud Schiappa, Claude El Kouri, Frédéric Bost, Jean-Laurent Deville, Dominique Besson, Tifenn Lharidon, Gerard Cavaglione, Werner Hilgers
Publikováno v:
Journal of Clinical Oncology. 37:5004-5004
5004 Background: Docetaxel (DOCE) is a standard of care in metastatic castration-resistant prostate cancer (mCRPC). Several retrospective cohort studies suggest a decrease in PC incidence and mortality with metformin (MET). MET has also demonstrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9740a3b4773cfd1dbc1da55e78ec566
https://doi.org/10.1200/jco.2019.37.15_suppl.5004
https://doi.org/10.1200/jco.2019.37.15_suppl.5004
Autor:
Olivier Tredan, Charlotte Proudhon, C. Orsini, N. Madranges, A. Mailliez, Anthony Gonçalves, I. Desmoulins, J. Grenier, Sophie Abadie-Lacourtoisie, Paul Cottu, T Grellety, Jérôme Dauba, M. Mousseau, François-Clément Bidard, Florence Dalenc, F. Del Piano, Benoit You, Florence Coussy, Mahasti Saghatchian, Marina Pulido, Tifenn Lharidon, Gaëtan MacGrogan, Hervé Bonnefoi
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2016, 27 (5), pp.812-818. ⟨10.1093/annonc/mdw067⟩
Annals of Oncology, Elsevier, 2016, 27 (5), pp.812-818. ⟨10.1093/annonc/mdw067⟩
International audience; BACKGROUND: Several expression array studies identified molecular apocrine breast cancer (BC) as a subtype that expresses androgen receptor (AR) but not estrogen receptor alpha. We carried out a multicentre single-arm phase II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cdb5208f5bc699ad967c742a5e33d01
https://hal.archives-ouvertes.fr/hal-01791274
https://hal.archives-ouvertes.fr/hal-01791274
Autor:
T. Nguyen Tan Hon, Geraldine Martineau, Y. Tazi, G. Gravis, Marine Gross-Goupil, P. Beuzeboc, Aude Flechon, M. Deblock, Remy Delva, Christine Theodore, Tifenn Lharidon, F. Joly Lobbedez, Giulia Baciarello, Isabelle Borget, Caroline Cheneau, Philippe Barthélémy, Stéphane Culine, J.-F. Berdah, Karim Fizazi, E. Bompas
Publikováno v:
Web of Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee688bc627d0f336047c1d365d3af95
https://doi.org/10.1093/annonc/mdx370.019
https://doi.org/10.1093/annonc/mdx370.019
Autor:
Jérôme Meunier, Aline Guillot, Eric Voog, Tifenn Lharidon, Delphine Aubert, Gwenaelle Gravis Mescam, Christine Theodore
Publikováno v:
Journal of Clinical Oncology. 33:e15635-e15635
e15635 Background: The mammalian target of rapamycin pathway has been shown to be upregulated in UC ad represents a potentiel target for therapeutic intervention. Methods: The present study is a si...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::636adaf50f32112c9cda8606c5b94141
https://doi.org/10.1200/jco.2015.33.15_suppl.e15635
https://doi.org/10.1200/jco.2015.33.15_suppl.e15635
Autor:
N. Dohollou, Olivier Tredan, J-M Ferrero, Paul-Henri Cottu, P. de Cremoux, B. Lucas, Hervé Bonnefoi, Jérôme Dauba, J-Y Pierga, Carol Alliot, Tifenn Lharidon, Gaëtan MacGrogan, M. Leheurteur, F. Del Piano, Benoit You, Florence Dalenc, Audrey Mailliez, C. Orsini, Marina Pulido, A. Gonçalves
Publikováno v:
Annals of Oncology. 25:iv135
Background: The molecular apocrine breast cancer subset has recently been identified. These tumours are estrogen receptor (ER) negative but are characterised by the expression of many genes expressed by ER-positive luminal tumours and, interestingly,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bc898652fed7f50212a806e9f8bbfc3
https://doi.org/10.1093/annonc/mdu329.60
https://doi.org/10.1093/annonc/mdu329.60